Josefina holds a PhD in Bioengineering from Universidad Miguel Hernández de Elche (2005), an MSc in Bioengineering (UMH, 2000) and a degree in Physical Sciences from Universitat de València (1998). She joined UCAM in 2006 as a Profesor Contratado Doctor (PDI) at the Escuela Politécnica Superior, where she has built a research line on medical biophysics and computational drug discovery.

Her research has covered the reconstruction of endocrine pancreatic function, the electrophysiological characterisation of insulin-producing cells derived from stem cells, and the clinical application of infrared thermography for the follow-up of muscular dystrophies. Earlier in her career she was a postdoctoral researcher at the Faculty of Medicine, Lund University Hospital (Sweden), and worked with the Wallenberg Neuroscience Center and the CABIMER stem-cell centre.

Within BIO-HPC, she contributes to the computational chemistry track — co-author on the group’s antiviral repurposing work (Kukoamine A, Zeaxanthin, Clexane as furin inhibitors) and co-inventor on related Spanish patents. She has been an invited speaker at the Max Planck Institute and at multiple international forums on bioengineering and rare diseases.